STOCK TITAN

Bioxytran Turns Science into Everyday Wellness with Launch of Its First Two Nutraceutical Products 

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Bioxytran (BIXT) has launched its first two nutraceutical products, expanding beyond its pharmaceutical pipeline into the consumer wellness market.

A-SUQAR is formulated to help maintain healthy blood sugar levels after meals, while V-LO is formulated to support healthy immune function. Both are available immediately through the company's online store. The products use ingredients that are Generally Recognized as Safe (GRAS), are manufactured in a certified facility and underwent independent third-party testing. The product statements have not been evaluated by the Food and Drug Administration, and neither product is intended to diagnose, treat, cure or prevent disease.

Loading...
Loading translation...
1 point · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

0 major · 0 points

How the balance works

Positive

  • Moderate pointLaunch of A-SUQAR and V-LO, Bioxytran's first two nutraceutical products, expands its business into consumer wellness.

Negative

  • None.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Company applies its carbohydrate-chemistry expertise to consumer wellness with a post-meal blood sugar supplement and an immune support supplement 

Boston, Mass.,, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Bioxytran, Inc. (OTCQB: BIXT) ("Bioxytran" or the "Company"), a clinical-stage biotechnology company developing platform technologies spanning Glycovirology, hypoxia, and degenerative diseases, today announced the launch two nutraceutical products: A-SUQAR, a supplement formulated to help maintain healthy blood sugar levels after meals, and V-LO, a supplement formulated to support healthy immune function. These statements have not been evaluated by the Food and Drug Administration, and the products are not intended to diagnose, treat, cure, or prevent any disease. 

The launch marks Bioxytran's expansion beyond its pharmaceutical pipeline into the consumer wellness market. A-SUQAR and V-LO are available beginning immediately at https://bioxytran.myshopify.com/ 

"For years, our team has worked on complex therapeutics for critical care and infectious diseases. Today we are bringing that same science directly to people's doorsteps," said David Platt, Ph.D., Chief Executive Officer of Bioxytran. "Our entry into nutraceuticals is driven by a simple principle: apply rigorous scientific standards to everyday health. We have held these products to the same diligence we apply to our drug programs, so consumers get a high-quality, science-backed supplement they can trust." 

The Products 

A-SUQAR – Metabolic Support. A-SUQAR is designed to help maintain healthy blood sugar levels after meals. It works by slowing the breakdown and absorption of dietary sugars in the intestine, supporting healthy metabolism and balanced energy throughout the day. 

V-LO – Immune Support. V-LO is formulated to support the body's natural immune defenses, helping people stay strong and resilient through the seasons. 

Built on Safety and Quality 

Both products draw on Bioxytran's expertise in complex carbohydrate chemistry and are formulated with ingredients that are Generally Recognized as Safe (GRAS). The products are manufactured in a certified facility and were tested by third independent party. 

Message to Shareholders and Friends 

"Our shareholders and friends, are the backbone of Bioxytran," said Dr. Platt. "We believe the best way to show the value of our work is to experience it firsthand. I invite you to try these products and make them part of your everyday routine. Thank you for your continued faith in Bioxytran. We look forward to sharing more updates on our progress." 

About Bioxytran, Inc. 

Bioxytran, Inc. (OTCQB: BIXT) is a clinical-stage biotechnology company developing platform technologies spanning Glycovirology, hypoxia, and degenerative diseases. The Company is now also applying its scientific expertise to high-quality nutraceutical products. For more information, visit www.bioxytraninc.com. 

Forward-Looking Statements 

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the launch, availability, market acceptance, and potential benefits of the Company's nutraceutical products and the Company's growth. Words such as "believe," "expect," "intend," "plan," "may," "will," and similar expressions identify forward-looking statements. These statements are based on current expectations and involve risks and uncertainties, including risks related to manufacturing and supply, consumer demand, competition, regulatory requirements applicable to dietary supplements, and the Company's ability to fund its operations. Actual results may differ materially. Additional risks are described in the Company's filings with the U.S. Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Bioxytran undertakes no obligation to update any forward-looking statement, except as required by law. 

Contact 

David Platt, Ph.D. Chief Executive Officer Bioxytran, Inc.

75 Second Avenue, Needham, MA 02494

617-454-1199 

info@bioxytraninc.com 

 www.bioxytraninc.com 

###


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What are Bioxytran's first two nutraceutical products?

Bioxytran's first two nutraceutical products are A-SUQAR, formulated to help maintain healthy blood sugar levels after meals, and V-LO, formulated to support healthy immune function. Both are available immediately through the company's online store.

Keep reading